The WNK/SPAK and IRBIT/PP1 pathways in epithelial fluid and electrolyte Transport

Physiology

Volumn 27, Issue 5, 2012, Pages 291-299

  Park, Seonghee ^a,b   Hong, Jeong Hee ^a   Ohana, Ehud ^a   Muallem, Shmuel ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b Ewha Womans University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CLECL1 PROTEIN, HUMAN; LECTIN; MEMBRANE PROTEIN; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y4 RECEPTOR; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE; STK39 PROTEIN, HUMAN; WNK1 PROTEIN, HUMAN;

ELECTROLYTE BALANCE; EPITHELIUM CELL; HUMAN; ION TRANSPORT; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

EPITHELIAL CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ION TRANSPORT; LECTINS, C-TYPE; MEMBRANE PROTEINS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, NEUROPEPTIDE Y; SIGNAL TRANSDUCTION; WATER-ELECTROLYTE BALANCE;

EID: 84867169446     PISSN: 15489213     EISSN: 15489221     Source Type: Journal    
DOI: 10.1152/physiol.00028.2012     Document Type: Review

References (62)

1. Ando H, Mizutani A, Kiefer H, Tsuzurugi D, Michikawa T, Mikoshiba K. IRBIT suppresses IP3 receptor activity by competing with IP3 for the common binding site on the IP3 receptor. Mol Cell 22: 795-806, 2006.
2. Ando H, Mizutani A, Matsu-ura T, Mikoshiba K. IRBIT, a novel inositol 1,4,5-trisphosphate (IP3) receptor-binding protein, is released from the IP3 receptor upon IP3 binding to the receptor. J Biol Chem 278: 10602-10612, 2003.
3. Ando H, Mizutani A, Mikoshiba K. An IRBIT homologue lacks binding activity to inositol 1,4,5-trisphosphate receptor due to the unique N-terminal appendage. J Neurochem 109: 539-550, 2009.
4. Beneken J, Tu JC, Xiao B, Nuriya M, Yuan JP, Worley PF, Leahy DJ. Structure of the Homer EVH1 domain-peptide complex reveals a new twist in polyproline recognition. Neuron 26: 143-154, 2000.
5. -and cell volume. J Cell Physiol 219: 787-796, 2009.
6. Boron WF, Chen L, Parker MD. Modular structure of sodium-coupled bicarbonate transporters. J Exp Biol 212: 1697-1706, 2009.
7. Cai H, Cebotaru V, Wang YH, Zhang XM, Cebotaru L, Guggino SE, Guggino WB. WNK4 kinase regulates surface expression of the human sodium chloride cotransporter in mammalian cells. Kidney Int 69: 2162-2170, 2006.
8. Cheng CJ, Huang CL. Activation of PI3-kinase stimulates endocytosis of ROMK via Akt1/SGK1-dependent phosphor ylation of WNK1. J Am Soc Nephrol 22: 460-471, 2011.
9. Choate KA, Kahle KT, Wilson FH, Nelson-Williams C, Lifton RP. WNK1, a kinase mutated in inherited hypertension with hyperkalemia, localizes to diverse Cl-transporting epithelia. Proc Natl Acad Sci USA 100: 663-668, 2003.
10. Choe KP, Strange K. Evolutionarily conserved WNK and Ste20 kinases are essential for acute volume recovery and survival after hypertonic shrinkage in Caenorhabditis elegans. Am J Physiol Cell Physiol 293: C915-C927, 2007.
11. Delpire E. The mammalian family of sterile 20p-like protein kinases. Pflügers Arch 458: 953-967, 2009.
12. - cotransport in primary afferent neurons. J Physiol 588: 3365-3373, 2010.
13. Devogelaere B, Beullens M, Sammels E, Derua R, Waelkens E, van Lint J, Parys JB, Missiaen L, Bollen M, De Smedt H. Protein phosphatase-1 is a novel regulator of the interaction between IRBIT and the inositol 1,4,5-trisphosphate receptor. Biochem J 407: 303-311, 2007.
14. Devogelaere B, Nadif Kasri N, Derua R, Waelkens E, Calle-waert G, Missiaen L, Parys JB, De Smedt H. Binding of IRBIT to the IP3 receptor: determinants and functional effects. Biochem Biophys Res Commun 343: 49-56, 2006.
15. Devogelaere B, Sammels E, De Smedt H. The IRBIT domain adds new functions to the AHCY family. Bioessays 30: 642-652, 2008.
16. Dorwart MR, Shcheynikov N, Wang Y, Stippec S, Muallem S. SLC26A9 is a Cl channel regulated by the WNK kinases. J Physiol 584: 333-345, 2007.
17. Filippi BM, de los Heros P, Mehellou Y, Navratilova I, Gourlay R, Deak M, Plater L, Toth R, Zeqiraj E, Alessi DR. MO25 is a master regulator of SPAK/OSR1 and MST3/MST4/YSK1 protein kinases. EMBO J 30: 1730-1741, 2011.
18. - cotransporter serves as a regulatory scaffold for Ste20-related proline/alanine-rich kinase (SPAK) AND PP1. J Biol Chem 285: 14115-14121, 2010.
19. Gagnon KB, England R, Delpire E. Volume sensitivity of cation-Cl cotransporters is modulated by the interaction of two kinases: Ste20-related proline-alanine-rich kinase and WNK4. Am J Physiol Cell Physiol 290: C134-C142, 2006.
20. Gagnon KB, England R, Diehl L, Delpire E. Apoptosis-associated tyrosine kinase scaffolding of protein phosphatase 1 and SPAK reveals a novel pathway for Na-K-2C1 cotransporter regulation. Am J Physiol Cell Physiol 292: C1809-C1815, 2007.
21. Gagnon KB, Rios K, Delpire E. Functional insights into the activation mechanism of Ste20-related kinases. Cell Physiol Biochem 28: 1219-1230, 2011.
22. Geng Y, Byun N, Delpire E. Behavioral analysis of Ste20 kinase SPAK knockout mice. Behav Brain Res 208: 377-382, 2010.
23. Golbang AP, Cope G, Hamad A, Murthy M, Liu CH, Cuthbert AW, O'Shaughnessy KM. Regulation of the expression of the Na/Cl cotransporter by WNK4 and WNK1: evidence that accelerated dynamin-dependent endocytosis is not involved. Am J Physiol Renal Physiol 291: F1369-F1376, 2006.
24. He G, Wang HR, Huang SK, Huang CL. Intersectin links WNK kinases to endocytosis of ROMK1. J Clin Invest 117: 1078-1087, 2007.
25. He P, Zhang H, Yun CC. IRBIT, inositol 1,4,5-triphosphate (IP3) receptor-binding protein released with IP3, binds Na /H exchanger NHE3 and activates NHE3 activity in response to calcium. J Biol Chem 283: 33544-33553, 2008.
26. Hoorn EJ, Walsh SB, McCormick JA, Fursten-berg A, Yang CL, Roeschel T, Paliege A, Howie AJ, Conley J, Bachmann S, Unwin RJ, Ellison DH. The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension. Nat Med 17: 1304-1309, 2011.
27. Huang CL, Cha SK, Wang HR, Xie J, Cobb MH. WNKs: protein kinases with a unique kinase domain. Exp Mol Med 39: 565-573, 2007.
28. Kahle KT, Gimenez I, Hassan H, Wilson FH, Wong RD, Forbush B, Aronson PS, Lifton RP. WNK4 regulates apical and basolateral Clflux in extrarenal epithelia. Proc Natl Acad Sci USA 101: 2064-2069, 2004.
29. Kim DE, Chivian D, Baker D. Protein structure prediction and analysis using the Robetta server. Nucleic Acids Res 32: W526-W531, 2004.
30. Lan Y, Liu H, Ovitt CE, Jiang R. Generation of Osr1 conditional mutant mice. Genesis 49: 419-422, 2011.
31. Lee MG, Ohana E, Park HW, Yang D, Muallem S. Molecular mechanism of pancreatic and salivary gland fluid and HCO3 secretion. Physiol Rev 92: 39-74, 2012.
32. Lee SK, Boron WF, Parker MD. Relief of autoinhibition of the electrogenic Na-HCO3 [corrected] cotransporter NBCe1-B: role of IRBIT vs. aminoterminal truncation. Am J Physiol Cell Physiol 302: C518-C526, 2012.
33. McAlear SD, Liu X, Williams JB, McNicholas-Bevensee CM, Bevensee MO. Electrogenic Na/HCO3 cotransporter (NBCe1) variants expressed in Xenopus oocytes: functional comparison and roles of the amino and carboxy termini. J Gen Physiol 127: 639-658, 2006.
34. McCormick JA, Ellison DH. The WNKs: atypical protein kinases with pleiotropic actions. PhysiolRev 91: 177-219, 2011.
35. Melnikov S, Mayan H, Uchida S, Holtzman EJ, Farfel Z. Cyclosporine metabolic side effects: association with the WNK4 system. Eur J Clin Invest 41: 1113-1120, 2011.
36. Milburn CC, Boudeau J, Deak M, Alessi DR, van Aalten DM. Crystal structure of MO25 alpha in complex with the C terminus of the pseudo kinase STE20-related adaptor. Nat Struct Mol Biol 11: 193-200, 2004.
37. Min X, Lee BH, Cobb MH, Goldsmith EJ. Crystal structure of the kinase domain of WNK1, a kinase that causes a hereditary form of hypertension. Structure 12: 1303-1311, 2004.
38. O'Reilly M, Marshall E, Speirs HJ, Brown RW. WNK1, a gene within a novel blood pressure control pathway, tissue-specifically generates radically different isoforms with and without a kinase domain. J Am Soc Nephrol 14: 2447-2456, 2003.
39. Orlov SN, Mongin AA. Salt-sensing mechanisms in blood pressure regulation and hypertension. Am J Physiol Heart Circ Physiol 293: H1039-H2053, 2007.
40. - cotransporter is activated and phosphorylated at the amino-terminal domain upon intracellular chloride depletion. J Biol Chem 281: 28755-28763, 2006.
41. -]i and its role in pancreatic bicarbonate secretion. Gastroenterology 139: 620-631, 2010.
42. - cotransporter in the nervous system: evidence for a scaf-folding role of the kinase. J Biol Chem 278: 52848-52856, 2003.
43. Pushkin A, Kurtz I. SLC4 base (HCO3, CO3 2) transporters: classification, function, structure, genetic diseases, and knockout models. Am J Physiol Renal Physiol 290: F580-F599, 2006.
44. Richardson C, Alessi DR. The regulation of salt transport and blood pressure by the WNK-SPAK/ OSR1 signalling pathway. J Cell Sci 121: 3293-3304, 2008.
45. Roy J, Cyert MS. Cracking the phosphatase code: docking interactions determine substrate specificity. Sci Signal 2: re9, 2009.
46. San-Cristobal P, Ponce-Coria J, Vazquez N, Bobadilla NA, Gamba G. WNK3 and WNK4 aminoterminal domain defines their effect on the renal Na-Cl cotransporter. Am J Physiol Renal Physiol 295: F1199-F1206, 2008.
47. Shirakabe K, Priori G, Yamada H, Ando H, Horita S, Fujita T, Fujimoto I, Mizutani A, Seki G, Mikoshiba K. IRBIT, an inositol 1,4,5-trisphosphate receptor-binding protein, specifically binds to and activates pancreas-type Na /HCO3 cotransporter 1 (pNBC1). Proc Natl Acad Sci USA 103: 9542-9547, 2006.
48. Verissimo F, Jordan P. WNK kinases, a novel protein kinase subfamily in multi-cellular organisms. Oncogene 20: 5562-5569, 2001.
49. Villa F, Goebel J, Rafiqi FH, Deak M, Thastrup J, Alessi DR, van Aalten DM. Structural insights into the recognition of substrates and activators by the OSR1 kinase. EMBO Rep 8: 839-845, 2007.
50. Vitari AC, Deak M, Morrice NA, Alessi DR. The WNK1 and WNK4 protein kinases that are mutated in Gordon's hypertension syndrome phosphorylate and activate SPAK and OSR1 protein kinases. Biochem J 391: 17-24, 2005.
51. Wang HR, Liu Z, Huang CL. Domains of WNK1 kinase in the regulation of ROMK1. Am J PhysiolRenal Physiol 295: F438-F445, 2008.
52. Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I, Gunel M, Milford DV, Lipkin GW, Achard JM, Feely MP, Dussol B, Berland Y, Unwin RJ, Mayan H, Simon DB, Farfel Z, Jeunemaitre X, Lifton RP. Human hypertension caused by mutations in WNK kinases. Science 293: 1107-1112, 2001.
53. 2 signaling by excitable and nonexcitable cells. Cell Calcium 42: 363-371, 2007.
54. Xu B, English JM, Wilsbacher JL, Stippec S, Gold-smith EJ, Cobb MH. WNK1, a novel mammalian serine/threonine protein kinase lacking the catalytic lysine in subdomain II. J Biol Chem 275: 16795-16801, 2000.
55. Yang CL, Angell J, Mitchell R, Ellison DH. WNK kinases regulate thiazide-sensitive Na-Cl cotransport. J Clin Invest 111: 1039-1045, 2003.
56. Yang CL, Liu X, Paliege A, Zhu X, Bachmann S, Dawson DC, Ellison DH. WNK1 and WNK4 modulate CFTR activity. Biochem Biophys Res Commun 353: 535-540, 2007.
57. Yang CL, Zhu X, Wang Z, Subramanya AR, Ellison DH. Mechanisms of WNK1 and WNK4 interaction in the regulation of thiazide-sensitive NaCl cotransport. J Clin Invest 115: 1379-1387, 2005.
58. Yang D, Li Q, So I, Huang CL, Ando H, Mizutani A, Seki G, Mikoshiba K, Thomas PJ, Muallem S. IRBIT governs epithelial secretion in mice by antagonizing the WNK/SPAK kinase pathway. J Clin Invest 121: 956-965, 2011.
59. Yang D, Shcheynikov N, Muallem S. IRBIT: it is everywhere. Neurochem Res 36: 1166-1174, 2011.
60. Yang D, Shcheynikov N, Zeng W, Ohana E, So I, Ando H, Mizutani A, Mikoshiba K, Muallem S. IRBIT coordinates epithelial fluid and HCO3 secretion by stimulating the transporters pNBC1 and CFTR in the murine pancreatic duct. J Clin Invest 119: 193-202, 2009.
61. Yang SS, Lo YF, Wu CC, Lin SW, Yeh CJ, Chu P, Sytwu HK, Uchida S, Sasaki S, Lin SH. SPAK-knockout mice manifest Gitelman syndrome and impaired vasoconstriction. J Am Soc Nephrol 21: 1868-1877, 2010.
62. Zhou B, Zhuang J, Gu D, Wang H, Cebotaru L, Guggino WB, Cai H. WNK4 enhances the degradation of NCC through a sortilin-mediated lysosomal pathway. J Am Soc Nephrol 21: 82-92, 2010.